ClinicalTrials.gg
RecruitingNCT07531771Updated Apr 15, 2026

Comparative Effect of Pursed Lip Breathing Alone and Combined With Alternate Nostril Breathing on Pulmonary Function Test and Quality of Life in Patients in Grade I COPD Patients.

An interventional study of pursed lip breathing and Alternate Nostril breathing: in COPD Grade I, sponsored by Foundation University Islamabad. Recruiting at 1 site in Pakistan. Open to participants aged 40 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-04-15.

Sponsored by Foundation University Islamabad · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by May 2026, 6 months ago, but the record still lists the study as recruiting.
  • Started Feb 2026; still recruiting 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
40 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 78 studies in Pulmonary Disease, Chronic Obstructive with a site in Pakistan — 28 open to participants now, 28 under way, 1 of them phase 3. Pulmonary Disease, Chronic Obstructive · Pakistan.

Planned enrollment
52nd of 75
40 · median 48
Started
2026
with 11 others
No phase
72 of 78
27 open now
Primary completion
2026-05
later than 17 of 27 live
Registered
69th of 78
by date
Lead sponsor
6 of 78
Foundation University Islamabad

Among the 78 studies in Pulmonary Disease, Chronic Obstructive with a site in Pakistan, this one is the 52nd largest by planned enrollment of the 75 interventional ones that give a count, is one of 12 that started in 2026, is one of 72 with no phase, reaches primary completion later than 17 of the 27 other live ones, and was the 69th registered.

Pulmonary Disease, Chronic Obstructive

5,529 studies on the registry are indexed under Pulmonary Disease, Chronic Obstructive; 858 are open to participants now.

Browse Pulmonary Disease, Chronic Obstructive studies →

Open to participants now

28 of the 78 studies in Pulmonary Disease, Chronic Obstructive with a site in Pakistan are open now. Recruiting first, the newest first:

22 more — sign in →

All 28 open studies →

A study can be open while its sites in Pakistan have not opened yet or have stopped. Only those recruiting at a site in Pakistan →

Who these studies take

Of the 560 Pulmonary Disease, Chronic Obstructive studies recruiting now, 307 (55%) set no upper age limit and 82 (15%) stop at 75 or younger; 30 take children under 18; 88 take healthy volunteers.

This study: 40 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 78 studies in Pulmonary Disease, Chronic Obstructive with a site in Pakistan, or all of them as a file.
02

Study summary

Chronic Obstructive Pulmonary Disease (COPD) is a progressive respiratory disorder characterized by airflow limitation, breathlessness, and reduced quality of life. Breathing exercises are commonly used in pulmonary rehabilitation to improve respiratory efficiency and functional capacity. Among these techniques, pursed lip breathing (PLB) helps slow expiration, reduce air trapping, and improve ventilation, while alternate nostril breathing (ANB), a yogic breathing technique, may enhance respiratory control and relaxation.

The purpose of this study is to determine the effects of pursed lip breathing alone compared with the combined effect of pursed lip breathing and alternate nostril breathing on pulmonary function and quality of life in patients with Grade I COPD. This randomized controlled trial will include approximately 40 participants diagnosed with mild COPD. The participants will be divided into two groups: one group will perform pursed lip breathing exercises, while the other group will perform a combination of pursed lip breathing and alternate nostril breathing.

Pulmonary function tests and quality of life assessments will be used as outcome measures to evaluate the effectiveness of these interventions. The study aims to determine whether combining both breathing techniques provides greater improvement in respiratory function and patient well being than pursed lip breathing alone. The findings may contribute to developing more effective physiotherapy based pulmonary rehabilitation strategies for patients with COPD.

Read the detailed description

Chronic Obstructive Pulmonary Disease (COPD) is a progressive respiratory condition characterized by persistent airflow limitation, chronic inflammation of the airways, and reduced lung function. It is commonly associated with long term exposure to harmful particles or gases, especially cigarette smoke. Patients with COPD often experience symptoms such as breathlessness, chronic cough, sputum production, and reduced exercise tolerance, which significantly affect their daily activities and overall quality of life. Pulmonary rehabilitation, particularly breathing exercises, plays an important role in the physiotherapy management of COPD.

Among the commonly used breathing techniques, pursed lip breathing is widely recommended for patients with COPD. This technique helps slow down expiration, prevents airway collapse, reduces air trapping, and improves ventilation efficiency. As a result, it may decrease dyspnea and enhance oxygen exchange. Another breathing technique, alternate nostril breathing, is a yogic breathing exercise that promotes better control of respiration, improves relaxation, and may enhance respiratory muscle coordination.

The purpose of this study is to investigate the effect of pursed lip breathing alone and in combination with alternate nostril breathing on patients with Grade I COPD. The study aims to determine whether the combined use of these breathing techniques can provide additional benefits compared to pursed lip breathing alone. By improving breathing patterns and respiratory mechanics, these interventions may help patients manage symptoms more effectively and enhance their functional capacity.

This research will follow an interventional study design in which participants will be divided into two groups. One group will receive pursed lip breathing exercises, while the second group will perform both pursed lip breathing and alternate nostril breathing. The intervention will be conducted over a specified period under proper supervision and guidance.

The findings of this study may contribute to the development of more effective physiotherapy based breathing exercise programs for patients with mild COPD and may support the integration of combined breathing techniques in pulmonary rehabilitation programs.

03

Conditions studied

  • COPD Grade I

Keywords

  • COPD
  • breathing
  • exercise
  • pursed lip breathing
  • alternate nostril breathing
  • pulmonary functions
  • chest expansion
  • quality of life
04

Who can participate

Ages eligible
40 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients diagnosed with Grade I ( > 80% predicted)
  • Age between 40 to 65 years.
  • Both male and female patients.
  • Patients able to follow verbal instructions and perform breathing exercises.
  • Patients willing to provide written .

Exclusion criteria

Exclusion Criteria:

  • History of orthopedic conditions limiting sitting or breathing exercises.
  • Recent respiratory infections or exacerbations within the past 4 weeks.
  • Neurological or cognitive impairments.
  • Recent thoracic or abdominal surgeries.
  • Regular practitioners of yoga or alternate nostril breathing.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

FEV1

From a breathing test (spirometry): how much air you can blow out in the first second. Often given as a percentage of what is expected for your age, height and sex.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Active comparator
    Pursed lip breathing exercises

    Participants in Group A will perform pursed lip breathing exercises. In this technique, patients are instructed to inhale slowly through the nose and then exhale slowly through pursed lips, as if blowing out a candle. The expiration phase is prolonged to help reduce air trapping and improve ventilation. The exercise will be performed under supervision for the prescribed duration and frequency during the intervention period.

    Other: pursed lip breathing

  • Experimental
    Pursed lip breathing with alternate nostril breathing

    Participants in Group B will perform a combination of pursed lip breathing and alternate nostril breathing. Along with PLB, patients will practice alternate nostril breathing, a controlled breathing technique in which inhalation and exhalation occur alternately through one nostril at a time while the other nostril is gently closed using the fingers. This technique helps regulate breathing patterns, improve respiratory control, and promote relaxation. The exercises will be performed under supervision according to the prescribed duration and frequency during the intervention period.

    Other: Alternate Nostril breathing:

Interventions

  • Otherpursed lip breathing

    Alternate Nostril Breathing (ANB): Alternate nostril breathing is a controlled breathing technique commonly used in yogic practices to regulate breathing patterns. In this method, the individual inhales through one nostril while the other is closed, then exhales through the opposite nostril in an alternating pattern. This technique promotes relaxation, improves respiratory control, and may enhance lung function.

  • OtherAlternate Nostril breathing:

    Alternate nostril breathing is a simple technique where you inhale through one nostril and exhale through the other in a controlled pattern. It helps calm the mind and improves lung function. This breathing exercise can be beneficial in conditions like Chronic Obstructive Pulmonary Disease. Practicing it regularly enhances relaxation and balances the body.

06

What researchers measure

Primary outcomes

  1. Pulmonary Function Test

    Pulmonary function will be assessed using a calibrated spirometer to evaluate lung function parameters, including forced vital capacity (FVC), forced expiratory volume in one second (FEV₁), and FEV₁/FVC ratio. The test will be performed according to standardized guidelines, with participants instructed to perform maximal inspiration followed by a forceful and sustained expiration into the spirometer.

    Time frame: 04 weeks

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2026 (actual). Primary completion is estimated for May 2026, 2 months after the start.

Of 1,099 non-industry interventional studies with no phase under Pulmonary Disease, Chronic Obstructive, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 2 months is below that.

Counting every sponsor, half of 1,187 studies reached it within 22 months; a quarter within 10 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 6, 2026
First posted
Apr 15, 2026
StartActual
Feb 28, 2026
Primary completionEst.
May 15, 2026
CompletionEst.
May 15, 2026
Last update
Apr 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07531771
Responsible party
Sponsor
First posted
Apr 15, 2026
Start date
Feb 28, 2026
Primary completion
May 15, 2026 (estimated)
Completion
May 15, 2026 (estimated)
Last update
Apr 15, 2026

Study contacts

Haleema Sadia Sultan, MSPT-CPT
Contact
sadiaawan798@gmail.com
03325881596
Syeda Sumaira Batool, MSPT-CPT
Contact
sumira.batool@fui.edu.pk
03328868680

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion